Prevalence and distribution of the insertion element ISMag1 in Mycoplasma agalactiae

https://doi.org/10.1016/S0378-1135(02)00311-5Get rights and content

Abstract

In characterising Mycoplasma agalactiae strains from various European countries and from Africa, a new insertion sequence (IS), ISMag1, which is related to IS of the family of IS30 insertion elements, has been identified by DNA sequence analysis and Southern blot hybridisation. ISMag1 has a size of 1515 bp, and contains inverted repeats of 3 bp and a gene encoding the putative transposase on a single open reading frame. ISMag1 is present only in the rarely isolated serotypes E, F, G and H of M. agalactiae, where it is found in 1 to approximately 30 copies. The different patterns obtained by hybridisation of a labelled probe of ISMag1 to genomic DNA cut with various restriction enzymes correlate to some extent to the different serotypes and to variations of the nucleotide sequences of the uvrC genes of the different strains. Based on uvrC sequences, the strains of M. agalactiae carrying ISMag1 form a cluster, separate from the other strains. IS patterns obtained with ISMag1 allow a fine subtyping of the serotypes E, F, G and H of M. agalactiae for epidemiological studies. The potential role of ISMag1 and of its copy numbers on virulence and persistence of the respective strains requests further studies.

Introduction

Mycoplasma agalactiae is the causative agent of contagious agalactia (CA), a world-wide spread syndrome affecting ovine and caprine species, mainly characterised by mastitis, arthritis and keratoconjunctivitis. In lactating females, CA-induced mastitis leads to a rapid and severe reduction in milk secretion. The economic losses caused by these low milk yields are critical in regions depending on ewe or goat dairy products, such as the Mediterranean basin and eastern Europe, where control of CA is of particular importance (DaMassa et al., 1992, Bergonier et al., 1997). During natural infections, acute forms of the disease with marked clinical signs like agalactia are often observed, but chronic forms with only mild (or no) clinical signs also occur. Furthermore, experimental evidence confirmed that field strains of M. agalactiae may have various degrees of virulence in lactating ewes (Sanchis et al., 2000). The complete or partial lack of symptoms in certain infected animals makes the control of spread of M. agalactiae difficult. It is still unclear whether the major differences in virulence observed in M. agalactiae infected animals are due to variations between individual bacterial strains or due to variations in the physiological status of the individual hosts. This lack of clarity is mainly due to insufficient basic knowledge of the molecular mechanisms of pathogenicity and molecular genetics of this pathogen. Therefore, accurate and rational methods to subtype M. agalactiae for epidemiological purpose are of particular interest. Currently, the sole subtyping method of M. agalactiae is serotyping, based on a small set of monoclonal antigens targeting non-variable antigens of M. agalactiae (Bergonier et al., 1996). Serotypes A, B, C and D are most frequently encountered, while serotypes E, F, G and H are rarely isolated (Bergonier et al., 1996).

Recently, analysis of patterns of insertion sequences (IS) has been used extensively for epidemiological purposes (van Embden et al., 1993, Stanley et al., 1993, Small et al., 1994, Frey, 1998). Bacterial IS elements are mobile, transposable genetic elements of about 800–2500 bp which are often present in multiple copies on bacterial genomes (Galas and Chandler, 1989). Transposition of IS elements can cause deletions, insertions and inversions of genomic loci and thus contribute to the genetic variability of bacteria (Lewin, 1997). In mycoplasmas, however, there are only a few IS elements currently known (Bhugra and Dybvig, 1993, Frey et al., 1995, Calcutt et al., 1999, Vilei et al., 1999) but they contributed significantly to epidemiological studies of mycoplasmal diseases such as contagious bovine pleuropneumonia (Cheng et al., 1995, Vilei et al., 1999, March et al., 2000).

In this study, we report the discovery of a new IS element, named ISMag1, of M. agalactiae and describe its prevalence in the various serotypes.

Section snippets

Strains, growth conditions and DNA extraction

Mycoplasma strains used in this study are described in Table 1. They were grown in standard mycoplasma medium (Axcell Biotechnologies, Lyon, France) at 37 °C until stationary growth phase (Poumarat et al., 1991). Cells were harvested by centrifugation at 8000×g for 15 min, washed with phosphate-buffered saline (PBS) buffer (140 mM NaCl, 2.7 mM KCl, 15 mM KH2PO4, 8 mM Na2HPO4 (pH 7.4)) and re-suspended in PBS to a concentration of approximately 109 cells/ml. Mycoplasmal genomic DNA was extracted by the

Description of a new IS element associated with M. agalactiae

A new insertion element was detected while studying DNA clones encoding surface proteins of M. agalactiae. DNA sequence analysis revealed the presence of a transposase gene in the vicinity of the recently described surface antigen P30 (Fleury et al., 2001) in strain 3990. Comparison with sequences in the EMBL/GenBank databases using the BLAST programs evidenced a full IS element that is related to the family of IS30 and which was named ISMag1. ISMag1 has a length of 1515 bp, contains inverted

Discussion

A new IS element ISMag1, belonging to the IS30 family, has been detected in M. agalactiae. So far, this insertion element has been found in M. agalactiae strains of serotypes E, F, G or H, which are only rarely isolated from sheep and goat with CA. ISMag1 is not present in the more commonly isolated serotypes A, B, C and D. We have not found a correlation between the presence of ISMag1 in M. agalactiae and clinical or epidemiological parameters, but it should be noted that IS elements have been

Acknowledgements

We thank F. Poumarat (AFSSA, Lyon, France), F. Thiaucourt, (CIRAD-EMVT, Montpellier, France), and S. Tola (Istituto Zooprofilattico Sperimentale, Sassari, Italy) for the gift of strains. We are also grateful to Y. Schlatter for her practical help. This study is part of the European COST Action 826 on “Ruminant mycoplasmoses”. It was supported by grant no. C96.0073 of the Swiss Ministry of Education and Science, and by the Swiss Federal Veterinary Office.

References (29)

  • A. Bairoch et al.

    The PROSITE database, its status in 1995

    Nucl. Acids Res.

    (1995)
  • D. Bergonier et al.

    Contagious agalactia of small ruminants: current knowledge concerning epidemiology, diagnosis and control

    Rev. Sci. Tech.

    (1997)
  • B. Bhugra et al.

    Identification and characterisation of IS1138, a transposable element from Mycoplasma-Pulmonis that belongs to the IS3 family

    Mol. Microbiol.

    (1993)
  • M.J. Calcutt et al.

    IS1630 of Mycoplasma fermentans, a novel IS30-type insertion element that targets and duplicates inverted repeats of variable length and sequence during insertion

    J. Bacteriol.

    (1999)
  • Cited by (22)

    • A new predilection site of Mycoplasma bovis: Postsurgical seromas in beef cattle

      2016, Veterinary Microbiology
      Citation Excerpt :

      Briefly, genomic DNA was digested with the EcoRV restriction enzyme and DNA fragments were separated on a 0.7% agarose gel and further transferred on positively charged nylon membranes. ISMbov1 and ISMbov2 IS elements were further detected using digoxigenin-11-dUTP (dig) labelled probes as previously described (Pilo et al., 2003; Aebi et al., 2012). A total of 10 BB cows developed a postsurgical seroma between October 2014 and June 2015 (6 in farm 1, 1 in farm 2 and 3 in farm 3).

    • Field trial of two dual vaccines against Mycoplasma agalactiae and Mycoplasma mycoides subsp. mycoides (large colony type) in goats

      2007, Vaccine
      Citation Excerpt :

      Recently, specific and immunogenic proteins have been identified, which could be suitable for a future peptide vaccine against M. agalactiae [15–17]. However, the rapid development of this potential vaccine is improbable, mainly because the molecular mechanisms involved in the pathogenicity of this mycoplasma are still unclear [18]. Moreover, many authors do not recommend the use of single proteins as targets for mycoplasma vaccines [19], due to the high antigenic variability observed [4–6,20].

    View all citing articles on Scopus
    View full text